ABVC BioPharma Inc (ABVC)
0.7856
-0.07
(-8.44%)
USD |
NASDAQ |
May 31, 16:00
0.79
0.00 (0.00%)
After-Hours: 20:00
ABVC BioPharma Enterprise Value: 9.817M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 9.817M |
| May 30, 2024 | 10.60M |
| May 29, 2024 | 10.84M |
| May 28, 2024 | 11.33M |
| May 24, 2024 | 11.44M |
| May 23, 2024 | 12.45M |
| May 22, 2024 | 12.90M |
| May 21, 2024 | 13.01M |
| May 20, 2024 | 13.01M |
| May 17, 2024 | 12.90M |
| May 16, 2024 | 12.79M |
| May 15, 2024 | 13.01M |
| May 14, 2024 | 13.01M |
| May 13, 2024 | 12.90M |
| May 10, 2024 | 12.79M |
| May 09, 2024 | 12.91M |
| May 08, 2024 | 13.01M |
| May 07, 2024 | 12.49M |
| May 06, 2024 | 12.70M |
| May 03, 2024 | 12.70M |
| May 02, 2024 | 13.44M |
| May 01, 2024 | 13.22M |
| April 30, 2024 | 14.49M |
| April 29, 2024 | 16.08M |
| April 26, 2024 | 16.29M |
| Date | Value |
|---|---|
| April 25, 2024 | 18.08M |
| April 24, 2024 | 16.92M |
| April 23, 2024 | 15.55M |
| April 22, 2024 | 12.27M |
| April 19, 2024 | 11.75M |
| April 18, 2024 | 12.38M |
| April 17, 2024 | 12.06M |
| April 16, 2024 | 13.12M |
| April 15, 2024 | 12.80M |
| April 12, 2024 | 12.80M |
| April 11, 2024 | 13.44M |
| April 10, 2024 | 13.33M |
| April 09, 2024 | 13.75M |
| April 08, 2024 | 14.49M |
| April 05, 2024 | 14.70M |
| April 04, 2024 | 14.81M |
| April 03, 2024 | 15.06M |
| April 02, 2024 | 15.06M |
| April 01, 2024 | 15.91M |
| March 31, 2024 | 15.27M |
| March 28, 2024 | 14.91M |
| March 27, 2024 | 13.74M |
| March 26, 2024 | 14.59M |
| March 25, 2024 | 12.16M |
| March 22, 2024 | 12.37M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
5.806M
Minimum
Oct 06 2023
356.37M
Maximum
Jun 05 2019
68.67M
Average
62.43M
Median
May 06 2020
Enterprise Value Benchmarks
| NeuBase Therapeutics Inc (DELISTED) | -- |
| Sutro Biopharma Inc | 32.36M |
| Reviva Pharmaceuticals Holdings Inc | 26.33M |
| Flora Growth Corp | 13.89M |
| Journey Medical Corp | 69.28M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.933M |
| Revenue (Quarterly) | 0.0012M |
| Total Expenses (Quarterly) | 3.446M |
| EPS Diluted (Quarterly) | -0.40 |
| Gross Profit Margin (Quarterly) | 77.01% |
| Profit Margin (Quarterly) | -326.4K% |
| Earnings Yield | -291.9% |
| Normalized Earnings Yield | -290.21 |